Renibus Therapeutics Announces Presentation at 22nd Annual Needham Virtual Healthcare Conference

SOUTHLAKE, Texas, April 5, 2023 /PRNewswire/ — Renibus Therapeutics® (“Renibus”), a clinical-stage biotech company focusing on the prevention and treatment of cardio-renal diseases, today announced that company management will participate in the 22nd Annual Needham Virtual Healthcare Conference, taking place virtually from April 17-20, 2023. Frank Stonebanks, Renibus’ Co-CEO, will present a company overview on Wednesday, April 19, 2023 at 11:45 am ET. Renibus management will also participate in one-on-one meetings with investors during the conference. About Renibus Renibus is a clinical stage biopharmaceutical company dedicated to treating, improving and extending patients’ lives by developing breakthrough products to prevent disease…